Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1998-11-04
2000-06-13
Crane, L. Eric
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 74, 514 29, C07H 1708, A61K 3170
Patent
active
060751339
ABSTRACT:
Antimicrobial compounds having the formula as well as pharmaceutically acceptable sats, esters or prodrugs thereof, pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compounds.
REFERENCES:
patent: 5350839 (1994-09-01), Asaka et al.
patent: 5444051 (1995-08-01), Agouridas et al.
patent: 5527780 (1996-06-01), Agouridas et al.
patent: 5561118 (1996-10-01), Agouridas et al.
patent: 5591837 (1997-01-01), Asaka et al.
patent: 5631355 (1997-05-01), Asaka et al.
Pestka et al. (I), "Effect of Erythromycin Analogues on Binding of [.sup.14 C]Erythromycin to Escherichia coli Ribosomes," Antimicrobial Agents and Chemotherapy, 6(4), 479-488 (Oct. 1974).
Pestka et al. (II), "Correlation of Effects of Erythromycin Analogues on Intact Bacteria and on [.sup.14 C]Erythromycin Binding to Escherichia coli Ribosomes," Antimicrobial Agents and Chemotherapy, 6(4), 488-491 (Oct. 1974).
Pestka et al. (III), "Inhibition of [.sup.14 C]Chloramphenicol Binding to Escherichia coli Ribosomes by Erythromycin Derivatives," Antimicrobial Agents and Chemotherapy, 6(1), 39-45 (Jul. 1974).
Pestka et al. (IV), "Induction of Erythromycin Resistance in Staphylococcus aureus by Erythromycin Derivatives," Antimicrobial Agents and Chemotherapy, 9(1), 128-130 (Jan. 1976).
LeMahieu et al., "Glycoside Cleavage Reactions on Erythromycin A. Preparation of Erythronolide A," J. Medicinal Chem., 17(9), 953-956 (Sep. 1974).
Chu Daniel T.
Clark Richard F.
Griesgraber George
Ma Zhenkun
Or Yat Sun
Abbott Laboratories
Anand Mona
Chen Portia
Crane L. Eric
LandOfFree
6-O-substituted antibacterial erythromycin ketolides and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-O-substituted antibacterial erythromycin ketolides and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-O-substituted antibacterial erythromycin ketolides and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2069700